Australia markets open in 5 hours 36 minutes

Takeda Pharmaceutical Company Limited (TAK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
13.13-0.12 (-0.91%)
As of 02:24PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2025)Next year (2026)
No. of analysts1121
Avg. Estimate0.750.760.470.61
Low estimate0.750.760.380.61
High estimate0.750.760.570.61
Year ago EPSN/AN/A0.30.47
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2025)Next year (2026)
No. of analysts2233
Avg. Estimate6.58M6.66M26M26.4M
Low estimate6.55M6.56M25.08M25.48M
High estimate6.61M6.75M27.08M28.01M
Year ago salesN/AN/A27.35M26M
Sales growth (year/est)N/AN/A-4.90%1.50%
Earnings historyInvalid DateInvalid DateInvalid DateInvalid Date
Est. EPSN/AN/AN/AN/A
Actual EPSN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2025)Next year (2026)
Current estimate0.750.760.470.61
7 days ago0.760.770.480.62
30 days ago0.760.770.460.62
60 days ago0.790.80.480.64
90 days ago0.710.750.470.52
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2025)Next year (2026)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days111N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesTAKIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year56.70%N/AN/AN/A
Next year29.80%N/AN/AN/A
Next 5 years (per annum)0.02%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A